MDPI, Gofron, Krzysztof Ksawery, et al
E.GoricarK.Kores PlesnicarB.Plemenitas IljesA.DolzanV
Therefore, GLP-1 receptor agonists such as Semaglutide and Tirzepatide, that are resistant to DPP-4 enzymatic degradation, were developed as therapeutic peptides
Oracle AI Medical Insights, clinical administration of intravenous glutathione for protocols such as preventing chemotherapy-induced toxicity involves a dose of 1.5 g/m administered over a period of 15 minutes
Dual GLP-1R/GIP receptor agonists exert anti-neuroinflammatory and anti-neurodegenerative benefits in preclinical studies and improve memory function, synaptic health, and neurogenesis (Pathak et al., 2018